Motilax MPS (10+125) Tablet

Motilax MPS (10+125) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by USV-Corvette (US Vitamins Ltd). This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Cisapride, Methylpolysiloxane. This drug comes in the form of Tablet. The general packing available for this medicine consists of 10 Tablet and is priced at Rs 39 (arround $0.546 US Dollar)
Generic (Salt) Combination :(Cisapride+ Methylpolysiloxane)
Pharma Company :USV-Corvette (US Vitamins Ltd)
Brand Label :Motilax MPS (10+125)
Preparation Type :Tablet
Single Dose :1 Tablet
Composition (Fixed-Dose Combination) :
  • Cisapride-10 mg
  • Methylpolysiloxane-125 mg
Pack Size/Qty/Vol :10 Tablet
Price Unit :Rs 3.9 INR (arround $0.0546 US Dollar)
Price Pack :Rs 39 INR (arround $0.546 US Dollar)

Drug details for Motilax MPS (10+125)

Usage: Why is this medication prescribed?

The main active ingredients or salts in Motilax MPS (10+125) are :

  • Cisapride-10 mg
  • Methylpolysiloxane-125 mg

Cisapride
Indication (Prescribed for or used as): Cisapride is used to treat symptoms of nighttime heartburn in people who have not responded to other treatments.

For more details on Cisapride, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Cisapride..

Methylpolysiloxane
Indication (Prescribed for or used as):

For more details on Methylpolysiloxane, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Methylpolysiloxane..

Motilax MPS (10+125) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :

There are 8 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Motilax MPS (10+125), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Cisapride-10 mg Methylpolysiloxane-125 mg).
Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.

BrandPrice (Rs.)BrandPrice (Rs.)
Esorid MPS (10+125) 39.3Gastropen MPS (10+125) 34
Kemopride MPS (10+125) 34Progit MPS (10+125) 23.4
Prokine MPS (10+125) 35.23Pryde MPS (10+125) 35
Syspride MPS (125+10) 45Ulcipride MPS (10+125) 36

Search Drug Brands alphabetically